The Melt acquisition expands Harrow’s portfolio and underscores its commitment to innovative therapies.

Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it has completed the acquisition ...

Discover how conscious sedation is transforming gynecologic care by making essential procedures—like pap smears, IUD ...